Holen Sie sich die Stockscreener-App
32.62
0.35%
-0.1353
Schlusskurs vom Vortag:
$32.76
Offen:
$32.43
24-Stunden-Volumen:
16,273
Relative Volume:
0.04
Marktkapitalisierung:
$997.14M
Einnahmen:
$339.92M
Nettoeinkommen (Verlust:
$-12.83M
KGV:
-75.96
EPS:
-0.4295
Netto-Cashflow:
$4.52M
1W Leistung:
-2.32%
1M Leistung:
+1.92%
6M Leistung:
+20.82%
1J Leistung:
+32.44%
1-Tages-Spanne:
$32.00
$33.03
1-Wochen-Bereich:
$31.98
$34.00
52-Wochen-Spanne:
$17.72
$44.28
Castle Biosciences Inc Stock (CSTL) Company Profile
Firmenname
Castle Biosciences Inc
Sektor
Branche
Telefon
866-788-9007
Adresse
1500 W. PARKWOOD AVE., FRIENDSWOOD, TX
Compare CSTL vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
32.64 | 1.00B | 339.92M | -12.83M | 4.52M | -0.4295 |
TMO
Thermo Fisher Scientific Inc
|
603.56 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.21 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
324.81 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
256.66 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
IDXX
Idexx Laboratories Inc
|
518.88 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-04-30 | Eingeleitet | Lake Street | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | Bestätigt | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | BTIG Research | Buy |
| 2019-08-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-08-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-08-19 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten
SciBase receives additional order from Castle Biosciences, advancing the collaboration - Yahoo Finance
Bank of New York Mellon Corp Invests $2.34 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences Stock Price Forecast. Should You Buy CSTL? - StockInvest.us
Castle Biosciences, Inc. $CSTL Shares Sold by Bank of America Corp DE - MarketBeat
Castle Biosciences COO Oelschlager sells $138,642 in shares By Investing.com - Investing.com Nigeria
Castle Biosciences COO Oelschlager sells $138,642 in shares - Investing.com
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares By Investing.com - Investing.com South Africa
Castle Biosciences (NASDAQ:CSTL) Beats Estimates As Momentum Builds - Kalkine Media
Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 1,730 Shares - GuruFocus
Castle Biosciences (CSTL) Slips 2.4% to $32.62: Key Support in FocusNews Sentiment - vinanet.vn
Castle Biosciences CCO Tobin Juvenal sells $51,190 in shares - Investing.com
Empowered Funds LLC Acquires New Shares in Castle Biosciences, Inc. $CSTL - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells $412,609.60 in Stock - MarketBeat
CSTL stock gains as institutional investor builds position and recent results support growth story - AD HOC NEWS
Man Group plc Takes $2.59 Million Position in Castle Biosciences, Inc. $CSTL - MarketBeat
3,291,963 Shares in Castle Biosciences, Inc. $CSTL Purchased by BlackRock Inc. - MarketBeat
(CSTL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Castle Biosciences, Inc. $CSTL Shares Acquired by Algert Global LLC - MarketBeat
Castle Biosciences, Inc. (CSTL) Is Up 15.46% in One Week: What You Should Know - Yahoo Finance
Castle Biosciences Inc. (CSTL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Jefferies Financial Group Inc. Acquires New Shares in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences CCO Tobin Juvenal Sells 9,050 Shares via Rule 10b5-1 Plan - Kalkine Media
Castle Biosciences CCO Tobin W sells $317k in shares By Investing.com - Investing.com India
Castle Biosciences CCO Tobin W sells $317k in shares - Investing.com
Tobin Juvenal Sells 9,050 Shares of Castle Biosciences (NASDAQ:CSTL) Stock - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Makes New $7.91 Million Investment in Castle Biosciences, Inc. $CSTL - MarketBeat
Insider Selling: Castle Biosciences (NASDAQ:CSTL) COO Sells $426,257.28 in Stock - MarketBeat
Castle Biosciences (CSTL) Slides 2.77% as Shares Approach Key Support at $32.33Ichimoku Kumo Twist - vinanet.vn
Castle Biosciences COO Kristen M. Oelschlager Executes Three Stock Sales in Late August 2026 - Kalkine Media
Castle Biosciences CCO Tobin W sells $51,190 in stock By Investing.com - Investing.com Canada
Parkman Healthcare Partners LLC Invests $3.45 Million in Castle Biosciences, Inc. $CSTL - MarketBeat
Castle Biosciences CCO Tobin W sells $51,190 in stock - Investing.com
Castle Biosciences officer plans $841K share sale | CSTL SEC FilingForm 144 - Stock Titan
Castle Biosciences surges 67% after InvestingPro Fair Value call By Investing.com - Investing.com Nigeria
Castle Biosciences (NASDAQ:CSTL): Why Does Its Latest Move Matter Now? - Kalkine Media
Is Castle Biosciences Inc (CSTL) Overvalued After 3.9% Rally? GF - GuruFocus
CFO & Treasurer Of Castle Biosciences Sold 41% Of Their Shares - Sahm
Castle Biosciences to Participate in Upcoming Investor Conferences - Sahm
238,204 Shares in Castle Biosciences, Inc. $CSTL Acquired by Advisors Capital Management LLC - MarketBeat
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Castle Biosciences CCO Tobin W Juvenal Sells 1,730 Shares via 10b5-1 Trading Plan - Kalkine Media
Castle (CSTL) Results Versus Estimates: EPS Beats Its Estimate in the Current Update; After Earnings: The Stock Ends Up 5.75% for the Current SessionEarnings Season Outlook - vinanet.vn
Castle Biosciences CFO Frank Stokes Sells 24,908 Shares in Open Market Transaction - Kalkine Media
Castle Biosciences (CSTL) CFO sells 24,908 company shares - Stock Titan
Castle Biosciences (CSTL) Edges Lower to $29.66: Diagnostic Stock Holds Key Support ZoneProfitability Factor - vinanet.vn
Castle Biosciences Gets Approval for Dual Listing on Nasdaq Texas - marketscreener.com
Castle Biosciences gains dual listing on Nasdaq Texas By Investing.com - Investing.com Australia
Castle Biosciences gains dual listing on Nasdaq Texas - Investing.com
Castle Biosciences Approved for Dual Listing on Nasdaq Texas - PR Newswire
AIGH Capital Management LLC Buys Shares of 545,101 Castle Biosciences, Inc. $CSTL - MarketBeat
Quantinno Capital Management LP Purchases 36,144 Shares of Castle Biosciences, Inc. $CSTL - MarketBeat
Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.07%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):